Found: 12
Select item for more details and to access through your institution.
Doxycycline for the treatment of breast cancer-related lymphedema.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.1028926
- By:
- Publication type:
- Article
Lymphatics in Tumor Progression and Immunomodulation.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 4, p. 2127, doi. 10.3390/ijms23042127
- By:
- Publication type:
- Article
GLP-1 receptor agonist as an effective treatment for breast cancer-related lymphedema: a case report.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1392375
- By:
- Publication type:
- Article
Skin microbiome alterations in upper extremity secondary lymphedema.
- Published in:
- PLoS ONE, 2023, v. 17, n. 5, p. 1, doi. 10.1371/journal.pone.0283609
- By:
- Publication type:
- Article
Pharmacological Treatment of Secondary Lymphedema.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.828513
- By:
- Publication type:
- Article
Ramadan Fasting Exerts Immunomodulatory Effects: Insights from a Systematic Review.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.01144
- By:
- Publication type:
- Article
Dysregulation of Lymphatic Endothelial VEGFR3 Signaling in Disease.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 1, p. 68, doi. 10.3390/cells13010068
- By:
- Publication type:
- Article
Top 10 Resources in Global Surgery.
- Published in:
- Global Health: Science & Practice, 2020, v. 8, n. 3, p. 606, doi. 10.9745/ghsp-d-20-00050
- By:
- Publication type:
- Article
Autoimmune/Inflammatory Syndrome Induced by Adjuvants and Thyroid Autoimmunity.
- Published in:
- Frontiers in Endocrinology, 2017, v. 7/8, p. 1, doi. 10.3389/fendo.2016.00150
- By:
- Publication type:
- Article
Deep Frostbite: the Question of Adjuvant Treatment.
- Published in:
- Israel Medical Association Journal, 2016, v. 18, n. 1, p. 56
- By:
- Publication type:
- Article
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND).
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1457363
- By:
- Publication type:
- Article
Burnout and compassion fatigue: prevalence and associations among Israeli burn clinicians.
- Published in:
- Neuropsychiatric Disease & Treatment, 2017, v. 13, p. 1533, doi. 10.2147/NDT.S133181
- By:
- Publication type:
- Article